Optimization of PD-1 / PD-L1 Blockade to Increase NK Cells Cytotoxicity in Killing Cancer Cells: Article Review

References (22)

1. 1 Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape [DOI]
2. 2 Mechanisms of natural killer cell-mediated cellular cytotoxicity [DOI]
3. 3 Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation [DOI]
4. 4 Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization [DOI]
5. 5 Engineering Natural Killer Cells for Cancer Immunotherapy [DOI]
6. 6 Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma [DOI]
7. 7 Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL [DOI]
8. 8 The Role of PD-1 in Acute and Chronic Infection [DOI]
9. 9 PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis [DOI]
10. 10 The Role Of PD-1/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy [DOI]
11. 11 PD-1 Increases PTEN Phosphatase Activity While Decreasing PTEN Protein Stability by Inhibiting Casein Kinase 2 [DOI]
12. 12 PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells [DOI]
13. 13 Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned [DOI]
14. 14 PD-L1 blockade enhances anti-tumor efficacy of NK cells [DOI]
15. 15 The PD‐1/PD‐L1 (B7‐H1) Pathway in Chronic Infection‐Induced Cytotoxic T Lymphocyte Exhaustion [DOI]
16. 16 Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells [DOI]
17. 17 Immunotherapy of cancers comes of age [DOI]
18. 18 Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I [DOI]
19. 19 Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types [DOI]
20. 20 Mechanisms of Primary and Secondary Resistance to Immune Checkpoint Inhibitors in Cancer [DOI]
21. 21 Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C [DOI]
22. 22 Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study [DOI]

Cited by 0

No indexed citations yet.

Related research

• In vitro Antioxidant, Antimicrobial, Insecticidal and Cytotoxic Activities of the Medicinal Plants: Allamanda cathartica and Mimusops elengi — shares topic coverage
• Retracted: Bioenergetics of Human Cancer Cells and Normal Cells during Proliferation and Differentiation — shares topic coverage
• Anticancer and Antibacterial Activities of Polysaccharides Production from Radish (Raphanus sativus) and Lettuce (Lactuca sativa) Seeds in vitro — shares topic coverage
• The Effect of Different Ratio Combinations of Rice Husk Charcoal: Soil Media and Different NPK Fertilizer Rates on Growth and Fruit Yield of Okra (Abelmoschus esculentus L. Moench) — shares topic coverage
• Destabilization of Abnormal Methylation Enzymes as the Only Viable Option for the Elimination of Cancer Stem Cells to Save Cancer Patients — shares topic coverage